Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001704038 | SCV000521665 | likely benign | not provided | 2018-10-15 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 24728327) |
Labcorp Genetics |
RCV000475364 | SCV000552257 | benign | Tuberous sclerosis 1 | 2024-01-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000562597 | SCV000675427 | benign | Hereditary cancer-predisposing syndrome | 2022-04-06 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV000475364 | SCV002040108 | likely benign | Tuberous sclerosis 1 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000562597 | SCV002530904 | likely benign | Hereditary cancer-predisposing syndrome | 2021-12-22 | criteria provided, single submitter | curation | |
Laboratory of Molecular Epidemiology of Birth Defects, |
RCV003153402 | SCV003843513 | benign | Ovarian cancer | 2022-01-01 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV003997359 | SCV004814305 | uncertain significance | Tuberous sclerosis syndrome | 2023-06-28 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV000475364 | SCV005404711 | likely benign | Tuberous sclerosis 1 | 2024-08-08 | criteria provided, single submitter | clinical testing | This variant is considered likely benign. This variant has been observed at a population frequency that is significantly greater than expected given the associated disease prevalence and penetrance. |
ITMI | RCV000122188 | SCV000086405 | not provided | not specified | 2013-09-19 | no assertion provided | reference population |